Kota Fukumoto
Kota Fukumoto publishes mostly in Hematology, Pathology and Forensic Medicine and Molecular Biology, on topics such as Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments and T-cell and Retrovirus Studies.
- World rank
- #2,787,273 of 7,710,434 ranked researchers
- Rank in Japan
- #59,727 of 383,136
- Works
- 43
- Citations
- 574
- Citations per work
- 13.3
What does Kota Fukumoto research?
Kota Fukumoto's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2557.6%
- Medicine2557.6%
- Life Sciences1023.6%
- Everything else818.8%
- 1Hematology22% of their works
- 2Pathology and Forensic Medicine17% of their works
- 3Molecular Biology13% of their works
- 4Immunology10% of their works
- 5Oncology10% of their works
- 6Genetics8% of their works
Research topics
- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- T-cell and Retrovirus Studies
- Acute Myeloid Leukemia Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematological disorders and diagnostics
- Chronic Lymphocytic Leukemia Research
Which keywords describe Kota Fukumoto's research?
The keywords of their largest research topics: Lymphoma, Rituximab, Classification, Molecular Profiling, Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors and HTLV-1.
- FDG PET/CT
- Bone Marrow Biopsy
- Myelofibrosis
- Cardiac Amyloidosis
- AML
- HTLV-1
- International Myeloma Working Group
- Molecular Profiling
- Rituximab
- Lymphoma
- Classification
- Diagnosis Criteria
- Prognostic Factors
- Infection
- Acute Myeloid Leukemia
- JAK2 Mutation
- Transthyretin
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Lymphoma252 topics
- Rituximab212 topics
- Classification181 topic
- Molecular Profiling181 topic
- Diagnosis Criteria131 topic
- International Myeloma Working Group131 topic
- Prognostic Factors92 topics
- HTLV-171 topic
- Infection71 topic
- AML61 topic
- Acute Myeloid Leukemia61 topic
- Cardiac Amyloidosis51 topic
- JAK2 Mutation51 topic
- Myelofibrosis51 topic
- Transthyretin51 topic
- Bone Marrow Biopsy31 topic
- Chronic Lymphocytic Leukemia31 topic
- FDG PET/CT31 topic
- Genomic Aberrations31 topic
Where does Kota Fukumoto work?
Kota Fukumoto's main affiliation in the publication record is Kameda Medical Center, Japan.
How many publications and citations does Kota Fukumoto have?
OpenAlex counts 43 works and 574 citations for Kota Fukumoto, an h-index of 12, ranking #2,787,273 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kota Fukumoto. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.